PMID: 9541193Apr 16, 1998Paper

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

Breast Cancer Research and Treatment
E M BernsJ A Foekens

Abstract

Tamoxifen causes an objective response in about one-third of metastatic breast cancer and in only half of the breast cancer patients with estrogen receptor (ER) positive tumors. Steroid-receptor coactivator-1 (SRC-1) appears to be a general coactivator for steroid receptors and rate limiting factor necessary for efficient ER transactivation. We aimed to evaluate whether SRC-1 expression is an additional factor for prediction of response to first-line tamoxifen therapy in patients who developed recurrent disease. Here for the first time, we report on SRC-1 expression using a semi-quantitative RT-PCR in 21 primary breast tumors, seven mammary tumor cell-lines, 12 fibroblast cultures, and six normal breast tissues. The highest levels of SRC-1 were observed in normal tissues, intermediate levels in tumor tissues, and the lowest levels in breast tumor cell-lines. There was no relationship between the levels of SRC-1 in these primary tumors and the proportion of tumor cells within the surgical samples, nor with ER status. The median SRC-1 level was, however, lower in tumors from patients that did not respond to tamoxifen. Our findings suggest that high levels of SRC-1 indicate a favorable response to tamoxifen of patients with recurr...Continue Reading

References

Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R A GibbsC T Caskey
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·K E van RoozendaalJ A Foekens
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·C L SmithB W O'Malley
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·E M McInerneyB S Katzenellenbogen
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·T P YaoD M Livingston
Dec 1, 1996·Endocrine Reviews·M Beato, A Sánchez-Pacheco
May 1, 1997·Breast Cancer Research and Treatment·B S KatzenellenbogenE M McInerney

❮ Previous
Next ❯

Citations

Dec 15, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·H Sonoo, J Kurebayashi
Dec 6, 2005·Breast Cancer Research and Treatment·J K Hess-WilsonK E Knudsen
Apr 20, 2004·Critical Reviews in Oncology/hematology·Sandra Timm Pearce, V Craig Jordan
Jun 29, 2002·Molecular and Cellular Endocrinology·Takako SakamotoShin-ichi Hayashi
Dec 28, 1999·Molecular and Cellular Endocrinology·S ThenotV Cavailles
May 10, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·L C Murphy, P Watson
Nov 25, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Tatsuya ToyamaYoshitaka Fujii
Jan 5, 2002·Breast Cancer Research and Treatment·D O AzorsaP S Meltzer
Aug 25, 2009·Nature Reviews. Cancer·Jianming XuBert W O'Malley
Dec 19, 2000·BJU International·V J GnanapragasamD E Neal
Mar 10, 1999·Journal of the National Cancer Institute·S G HilsenbeckS A Fuqua
Mar 6, 2003·Journal of the National Cancer Institute·C Kent OsborneRachel Schiff
Sep 6, 2012·Endocrine Reviews·Bramanandam ManavathiRakesh Kumar
Oct 9, 2002·The American Journal of Pathology·Peng LiZhengxin Wang
Mar 20, 2002·Clinical Breast Cancer·J Geisler, P E Lønning
Sep 10, 2005·International Journal of Cancer. Journal International Du Cancer·Nanna SarvilinnaTimo Ylikomi
Aug 10, 2004·Surgery·Christopher B WeldonMatthew E Burow
Sep 20, 2005·Biochemical and Biophysical Research Communications·Rainer GirgertVolker Hanf
Mar 12, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Yanlei ZhangJiqiang Zhang
May 18, 2000·Cancer Treatment Reviews·E A Lien, P E Lønning
May 29, 2016·Drug Discovery Today·Tommaso De MarchiJohn W M Martens
Jun 4, 2019·Endocrinology·Malachi A Blundon, Subhamoy Dasgupta
Jun 7, 2002·The Journal of Clinical Endocrinology and Metabolism·Christopher W GregoryBruce A Lessey
Jan 8, 2004·Annals of Medicine·Leigh MurphyPeter Watson
May 20, 2017·Oncology Letters·Bartosz Adam FryczPaweł Piotr Jagodziński
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aisling M RedmondLeonie S Young
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marika J LinjaTapio Visakorpi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.